Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Using lucrative strategy, Johnson & Johnson seeks fifth use of anticlotting drug
Using lucrative strategy, Johnson & Johnson seeks fifth use of anticlotting drug
Using lucrative strategy, Johnson & Johnson seeks fifth use of anticlotting drug
Submitted by
admin
on May 10, 2012 - 11:00am
Source:
Yahoo/AP
News Tags:
Bayer
JNJ
Xarelto
bloodthinners
Headline:
Using lucrative strategy, Johnson & Johnson seeks fifth use of anticlotting drug
Do Not Allow Advertisers to Use My Personal information
